Promega Corporation

NGF Emax® ImmunoAssay System Technical Bulletin

Literature # TB226

The NGF Emax® ImmunoAssay System is designed for sensitive and specific detection of NGF (nerve growth factor)in an antibody sandwich format. In this format, flat-bottom 96-well plates are coated with Anti-NGF Polyclonal Antibody (pAb), which binds soluble NGF. The captured NGF is bound by a second specific monoclonal antibody (mAb). After washing, the amount of specifically bound mAb is detected using a species-specific antibody conjugated to horseradish peroxidase (HRP) as a tertiary reactant. The unbound conjugate is removed by washing, and following an incubation with a chromogenic substrate, the color change is measured. The amount of NGF in the test solutions is proportional to the color generated in the oxidation-reduction reaction. Using this system, NGF in tissue culture supernatants or tissue extracts can be quantitated.

The NGF Emax® ImmunoAssay System offers several benefits:


  • Specificity: Specific detection of NGF; typically less than 3%
    cross-reactivity with other neurotrophic factors at 10ng/ml.

  • Sensitivity: Detects a minimum of 7.8pg/ml of NGF.

  • Flexibility: Available in sizes for two or five 96-well ELISA
    plates; can configure plates as desired.

  • High Value: Optimized reagents and protocol.

Printed in USA. Revised 3/07.

PDF Icon Complete Protocol PDF (303kb)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »